Oragenics, Inc. (OGEN)
0.7832
+0.03
(+3.82%)
USD |
NYAM |
Dec 31, 16:00
0.7476
-0.04
(-4.55%)
After-Hours: 20:00
Oragenics Research and Development Expense (TTM): 3.387M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |
| Theriva Biologics, Inc. | 10.36M |
| NanoViricides, Inc. | 4.609M |
| Actinium Pharmaceuticals, Inc. | 20.82M |